🇺🇸 FDA
Pipeline program

A study to learn how vamorolone affects the body, how safe it is and how it moves into, through and out of the body in healthy male participants

SNT-I-VAM-026

Phase 1 other active

Quick answer

A study to learn how vamorolone affects the body, how safe it is and how it moves into, through and out of the body in healthy male participants for Phase I study in healthy male volunteers. Intended indication: Duchenne muscular dystrophy and Becker muscular dystrophy is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Phase I study in healthy male volunteers. Intended indication: Duchenne muscular dystrophy and Becker muscular dystrophy
Phase
Phase 1
Modality
other
Status
active

Clinical trials